Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · IEX Real-Time Price · USD

0.560

-0.024 (-4.16%)

At close: Apr 19, 2024, 4:00 PM

0.583

+0.023 (4.14%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Seres Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-113.72	-250.16	-65.58	-89.13	-70.28	-98.94	-89.38	-91.58	-54.78	-18	Upgrade
Depreciation & Amortization	15.11	11.85	9.22	8.89	9.83	7.86	7.26	4.21	0.73	0.19	Upgrade
Share-Based Compensation	34.1	25.48	20.22	8.82	8.34	16.64	17.36	16.86	9.69	2.07	Upgrade
Other Operating Activities	-52.85	-15.99	42.82	-22.2	-24.42	11.59	-10.76	114.44	3.51	4.09	Upgrade
Operating Cash Flow	-117.35	-228.82	6.69	-93.61	-76.52	-62.85	-75.52	43.92	-40.84	-10.36	Upgrade
Capital Expenditures	-7.98	-9.82	-9.57	-0.59	-1	-1.94	-4.68	-21.49	-4.36	-1	Upgrade
Change in Investments	18.56	92.25	73.65	-158.3	-29.52	114.26	60.38	-44.1	-131.37	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-1.4	-0.1	Upgrade
Investing Cash Flow	10.58	82.43	64.09	-158.89	-30.52	112.32	55.7	-65.59	-137.13	-1.1	Upgrade
Share Issuance / Repurchase	21.19	103.9	2.13	303.42	61.66	0.27	0.08	2.14	140.35	-0.81	Upgrade
Debt Issued / Paid	50.52	25.7	-0.95	0	24.58	0	0	0	-2.6	1.6	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-0.02	123.2	Upgrade
Financing Cash Flow	71.71	129.6	1.18	303.42	86.23	0.27	0.08	2.14	137.73	123.99	Upgrade
Exchange Rate Effect	0	-0	-0	0	0	0	0	0	0	0	Upgrade
Net Cash Flow	-35.07	-16.79	71.95	50.92	-20.81	49.73	-19.74	-19.53	-40.25	112.53	Upgrade
Free Cash Flow	-125.33	-238.64	-2.88	-94.2	-77.52	-64.79	-80.2	22.43	-45.21	-11.36	Upgrade
Free Cash Flow Margin	-99.21%	-3347.88%	-1.99%	-283.61%	-224.67%	-229.21%	-249.84%	103.05%	-	-	Upgrade
Free Cash Flow Per Share	-0.98	-2.21	-0.03	-1.18	-1.37	-1.59	-1.98	0.56	-1.92	-1.68	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).